- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Sequenom Inc (SQNM)
| Open: | 4.1500 | Day's Range: | 3.9700 - 4.2500 | Volume: | 3,002,232 |
|---|---|---|---|---|---|
| Previous Close: | 4.1100 | 52wk Range: | 2.6500 - 5.3600 | 1-Yr Rtn: | -3.53% |
Key Statistics for SQNM
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -1.0700 |
| Est. EPS (USD) (12/2013) | -0.7890 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 472.12 |
| Shares Outstanding (M) | 115.15 |
| 30 Day Average Volume | 2,573,034 |
| Price/Book (mrq) | 21.0664 |
| Price/Sale (ttm) | 4.1559 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SQNM
Company Profile & Key Executives for SQNM
Sequenom Inc. is a molecular diagnostic testing and genetics analysis company. The Company provides services, diagnostic testing, applications and genetic analysis products. Sequenom's products translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research.
| Harry F Hixson JrChairman/CEO | William J Welch "Bill"President/COO |
| Paul V MaierChief Financial Officer | Charles R CantorChief Scientific Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
SQNM News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page